Cargando…

Continuous gait monitoring discriminates community‐dwelling mild Alzheimer's disease from cognitively normal controls

INTRODUCTION: Few studies have explored whether gait measured continuously within a community setting can identify individuals with Alzheimer's disease (AD). This study tests the feasibility of this method to identify individuals at the earliest stage of AD. METHODS: Mild AD (n = 38) and cognit...

Descripción completa

Detalles Bibliográficos
Autores principales: Varma, Vijay R., Ghosal, Rahul, Hillel, Inbar, Volfson, Dmitri, Weiss, Jordan, Urbanek, Jacek, Hausdorff, Jeffrey M., Zipunnikov, Vadim, Watts, Amber
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864220/
https://www.ncbi.nlm.nih.gov/pubmed/33598530
http://dx.doi.org/10.1002/trc2.12131
_version_ 1783647624896708608
author Varma, Vijay R.
Ghosal, Rahul
Hillel, Inbar
Volfson, Dmitri
Weiss, Jordan
Urbanek, Jacek
Hausdorff, Jeffrey M.
Zipunnikov, Vadim
Watts, Amber
author_facet Varma, Vijay R.
Ghosal, Rahul
Hillel, Inbar
Volfson, Dmitri
Weiss, Jordan
Urbanek, Jacek
Hausdorff, Jeffrey M.
Zipunnikov, Vadim
Watts, Amber
author_sort Varma, Vijay R.
collection PubMed
description INTRODUCTION: Few studies have explored whether gait measured continuously within a community setting can identify individuals with Alzheimer's disease (AD). This study tests the feasibility of this method to identify individuals at the earliest stage of AD. METHODS: Mild AD (n = 38) and cognitively normal control (CNC; n = 48) participants from the University of Kansas Alzheimer's Disease Center Registry wore a GT3x+ accelerometer continuously for 7 days to assess gait. Penalized logistic regression with repeated five‐fold cross‐validation followed by adjusted logistic regression was used to identify gait metrics with the highest predictive performance in discriminating mild AD from CNC. RESULTS: Variability in step velocity and cadence had the highest predictive utility in identifying individuals with mild AD. Metrics were also associated with cognitive domains impacted in early AD. DISCUSSION: Continuous gait monitoring may be a scalable method to identify individuals at‐risk for developing dementia within large, population‐based studies.
format Online
Article
Text
id pubmed-7864220
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-78642202021-02-16 Continuous gait monitoring discriminates community‐dwelling mild Alzheimer's disease from cognitively normal controls Varma, Vijay R. Ghosal, Rahul Hillel, Inbar Volfson, Dmitri Weiss, Jordan Urbanek, Jacek Hausdorff, Jeffrey M. Zipunnikov, Vadim Watts, Amber Alzheimers Dement (N Y) Research Articles INTRODUCTION: Few studies have explored whether gait measured continuously within a community setting can identify individuals with Alzheimer's disease (AD). This study tests the feasibility of this method to identify individuals at the earliest stage of AD. METHODS: Mild AD (n = 38) and cognitively normal control (CNC; n = 48) participants from the University of Kansas Alzheimer's Disease Center Registry wore a GT3x+ accelerometer continuously for 7 days to assess gait. Penalized logistic regression with repeated five‐fold cross‐validation followed by adjusted logistic regression was used to identify gait metrics with the highest predictive performance in discriminating mild AD from CNC. RESULTS: Variability in step velocity and cadence had the highest predictive utility in identifying individuals with mild AD. Metrics were also associated with cognitive domains impacted in early AD. DISCUSSION: Continuous gait monitoring may be a scalable method to identify individuals at‐risk for developing dementia within large, population‐based studies. John Wiley and Sons Inc. 2021-02-05 /pmc/articles/PMC7864220/ /pubmed/33598530 http://dx.doi.org/10.1002/trc2.12131 Text en © 2020 The Authors. Alzheimer's & Dementia: Translational Research & Clinical Interventions published by Wiley Periodicals, Inc. on behalf of Alzheimer's Association. This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc-nd/4.0/ License, which permits use and distribution in any medium, provided the original work is properly cited, the use is non‐commercial and no modifications or adaptations are made.
spellingShingle Research Articles
Varma, Vijay R.
Ghosal, Rahul
Hillel, Inbar
Volfson, Dmitri
Weiss, Jordan
Urbanek, Jacek
Hausdorff, Jeffrey M.
Zipunnikov, Vadim
Watts, Amber
Continuous gait monitoring discriminates community‐dwelling mild Alzheimer's disease from cognitively normal controls
title Continuous gait monitoring discriminates community‐dwelling mild Alzheimer's disease from cognitively normal controls
title_full Continuous gait monitoring discriminates community‐dwelling mild Alzheimer's disease from cognitively normal controls
title_fullStr Continuous gait monitoring discriminates community‐dwelling mild Alzheimer's disease from cognitively normal controls
title_full_unstemmed Continuous gait monitoring discriminates community‐dwelling mild Alzheimer's disease from cognitively normal controls
title_short Continuous gait monitoring discriminates community‐dwelling mild Alzheimer's disease from cognitively normal controls
title_sort continuous gait monitoring discriminates community‐dwelling mild alzheimer's disease from cognitively normal controls
topic Research Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7864220/
https://www.ncbi.nlm.nih.gov/pubmed/33598530
http://dx.doi.org/10.1002/trc2.12131
work_keys_str_mv AT varmavijayr continuousgaitmonitoringdiscriminatescommunitydwellingmildalzheimersdiseasefromcognitivelynormalcontrols
AT ghosalrahul continuousgaitmonitoringdiscriminatescommunitydwellingmildalzheimersdiseasefromcognitivelynormalcontrols
AT hillelinbar continuousgaitmonitoringdiscriminatescommunitydwellingmildalzheimersdiseasefromcognitivelynormalcontrols
AT volfsondmitri continuousgaitmonitoringdiscriminatescommunitydwellingmildalzheimersdiseasefromcognitivelynormalcontrols
AT weissjordan continuousgaitmonitoringdiscriminatescommunitydwellingmildalzheimersdiseasefromcognitivelynormalcontrols
AT urbanekjacek continuousgaitmonitoringdiscriminatescommunitydwellingmildalzheimersdiseasefromcognitivelynormalcontrols
AT hausdorffjeffreym continuousgaitmonitoringdiscriminatescommunitydwellingmildalzheimersdiseasefromcognitivelynormalcontrols
AT zipunnikovvadim continuousgaitmonitoringdiscriminatescommunitydwellingmildalzheimersdiseasefromcognitivelynormalcontrols
AT wattsamber continuousgaitmonitoringdiscriminatescommunitydwellingmildalzheimersdiseasefromcognitivelynormalcontrols